Carol Sartorius
Concepts (316)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 52 | 2025 | 2140 | 6.570 |
Why?
| Receptors, Progesterone | 35 | 2024 | 343 | 6.020 |
Why?
| Progesterone | 14 | 2021 | 245 | 3.620 |
Why?
| Keratin-5 | 9 | 2022 | 50 | 3.350 |
Why?
| Receptors, Estrogen | 27 | 2025 | 426 | 3.000 |
Why?
| Progestins | 12 | 2021 | 78 | 2.570 |
Why?
| Neoplastic Stem Cells | 12 | 2020 | 379 | 2.290 |
Why?
| Estrogens | 9 | 2018 | 346 | 1.650 |
Why?
| Drug Resistance, Neoplasm | 9 | 2025 | 756 | 1.410 |
Why?
| Cell Line, Tumor | 26 | 2025 | 3202 | 1.400 |
Why?
| Estrogen Receptor alpha | 5 | 2022 | 133 | 1.190 |
Why?
| Cancer-Associated Fibroblasts | 2 | 2024 | 13 | 1.040 |
Why?
| Gene Expression Regulation, Neoplastic | 17 | 2025 | 1344 | 1.010 |
Why?
| Fatty Acid Synthase, Type I | 1 | 2025 | 11 | 0.950 |
Why?
| Receptors, Androgen | 5 | 2021 | 147 | 0.900 |
Why?
| Lipid Metabolism | 2 | 2025 | 497 | 0.890 |
Why?
| Antineoplastic Agents, Hormonal | 11 | 2025 | 157 | 0.820 |
Why?
| Keratin-17 | 1 | 2022 | 4 | 0.810 |
Why?
| Xenograft Model Antitumor Assays | 10 | 2020 | 812 | 0.800 |
Why?
| Triglycerides | 1 | 2025 | 527 | 0.790 |
Why?
| Cell Proliferation | 15 | 2025 | 2375 | 0.780 |
Why?
| Tamoxifen | 8 | 2025 | 199 | 0.760 |
Why?
| Estradiol | 8 | 2016 | 494 | 0.740 |
Why?
| Biomarkers, Tumor | 8 | 2022 | 1173 | 0.710 |
Why?
| Mammary Glands, Animal | 3 | 2012 | 120 | 0.700 |
Why?
| Carcinoma, Lobular | 1 | 2020 | 48 | 0.660 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2020 | 82 | 0.650 |
Why?
| Receptor, ErbB-2 | 4 | 2020 | 326 | 0.630 |
Why?
| Female | 53 | 2025 | 68551 | 0.600 |
Why?
| Mice | 33 | 2020 | 16915 | 0.580 |
Why?
| beta Catenin | 1 | 2020 | 223 | 0.580 |
Why?
| Retinoic Acid Receptor alpha | 1 | 2017 | 15 | 0.560 |
Why?
| RNA Polymerase III | 1 | 2017 | 26 | 0.560 |
Why?
| Receptors, Retinoic Acid | 1 | 2017 | 51 | 0.550 |
Why?
| Stem Cells | 2 | 2011 | 574 | 0.520 |
Why?
| MicroRNAs | 4 | 2015 | 676 | 0.500 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2015 | 197 | 0.500 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 35 | 0.490 |
Why?
| Animals | 39 | 2024 | 35309 | 0.490 |
Why?
| Tumor Suppressor Proteins | 2 | 2015 | 314 | 0.490 |
Why?
| Paracrine Communication | 1 | 2015 | 61 | 0.480 |
Why?
| Mice, SCID | 6 | 2020 | 350 | 0.480 |
Why?
| Humans | 66 | 2025 | 129266 | 0.470 |
Why?
| Neoplasms, Hormone-Dependent | 2 | 2012 | 38 | 0.460 |
Why?
| STAT5 Transcription Factor | 1 | 2014 | 48 | 0.450 |
Why?
| Cisplatin | 1 | 2015 | 299 | 0.430 |
Why?
| Astrocytes | 1 | 2015 | 196 | 0.430 |
Why?
| Mice, Inbred NOD | 5 | 2020 | 588 | 0.420 |
Why?
| Signal Transduction | 9 | 2021 | 4926 | 0.420 |
Why?
| Tumor Microenvironment | 7 | 2021 | 631 | 0.410 |
Why?
| Tumor Cells, Cultured | 10 | 2020 | 942 | 0.410 |
Why?
| Gene Expression Profiling | 13 | 2020 | 1688 | 0.410 |
Why?
| Ovarian Neoplasms | 2 | 2015 | 489 | 0.390 |
Why?
| Heterografts | 5 | 2020 | 131 | 0.390 |
Why?
| Transcriptome | 4 | 2020 | 874 | 0.380 |
Why?
| Medroxyprogesterone Acetate | 2 | 2015 | 35 | 0.370 |
Why?
| Mammary Glands, Human | 1 | 2011 | 64 | 0.360 |
Why?
| Hyaluronan Receptors | 6 | 2014 | 96 | 0.340 |
Why?
| MCF-7 Cells | 7 | 2022 | 116 | 0.340 |
Why?
| Carcinogenesis | 2 | 2020 | 213 | 0.300 |
Why?
| Estrogen Replacement Therapy | 1 | 2008 | 137 | 0.280 |
Why?
| Antineoplastic Agents | 2 | 2015 | 2054 | 0.270 |
Why?
| Androgens | 2 | 2021 | 178 | 0.270 |
Why?
| Brain Neoplasms | 1 | 2015 | 1143 | 0.260 |
Why?
| Mice, Nude | 6 | 2015 | 682 | 0.250 |
Why?
| Lymphatic Metastasis | 5 | 2017 | 320 | 0.250 |
Why?
| Transplantation, Heterologous | 6 | 2016 | 192 | 0.240 |
Why?
| Antigens, CD | 2 | 2020 | 489 | 0.240 |
Why?
| DNA-Binding Proteins | 3 | 2015 | 1446 | 0.230 |
Why?
| Neoplasm Recurrence, Local | 2 | 2022 | 958 | 0.230 |
Why?
| Models, Theoretical | 1 | 2008 | 546 | 0.230 |
Why?
| Apoptosis | 6 | 2017 | 2499 | 0.230 |
Why?
| Promoter Regions, Genetic | 5 | 2017 | 1204 | 0.220 |
Why?
| Myosin Heavy Chains | 3 | 2001 | 170 | 0.220 |
Why?
| Cell Transformation, Neoplastic | 2 | 2016 | 327 | 0.220 |
Why?
| Down-Regulation | 3 | 2015 | 636 | 0.210 |
Why?
| Pharmacology, Clinical | 1 | 2023 | 9 | 0.210 |
Why?
| Cyclic AMP | 3 | 1995 | 237 | 0.210 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2020 | 66 | 0.210 |
Why?
| Nuclear Proteins | 2 | 2015 | 659 | 0.200 |
Why?
| Mammary Neoplasms, Animal | 1 | 2022 | 30 | 0.200 |
Why?
| Neoplasm Transplantation | 3 | 2016 | 256 | 0.200 |
Why?
| Cell Communication | 1 | 2024 | 300 | 0.200 |
Why?
| Homeodomain Proteins | 3 | 2018 | 495 | 0.200 |
Why?
| Vimentin | 1 | 2022 | 50 | 0.190 |
Why?
| Gene Knockout Techniques | 2 | 2020 | 109 | 0.190 |
Why?
| Disease Progression | 5 | 2021 | 2630 | 0.190 |
Why?
| Cell-Free Nucleic Acids | 1 | 2022 | 32 | 0.190 |
Why?
| Cell Division | 1 | 2003 | 796 | 0.180 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2015 | 509 | 0.180 |
Why?
| Transcription Factors | 5 | 2023 | 1647 | 0.180 |
Why?
| Insulin Receptor Substrate Proteins | 1 | 2020 | 59 | 0.180 |
Why?
| Doxorubicin | 1 | 2022 | 328 | 0.180 |
Why?
| Leukocytes, Mononuclear | 2 | 2020 | 545 | 0.170 |
Why?
| Thyroid Hormones | 1 | 2020 | 55 | 0.170 |
Why?
| Antigens, Nuclear | 1 | 2000 | 20 | 0.170 |
Why?
| Transcription, Genetic | 6 | 2020 | 1416 | 0.170 |
Why?
| Neoplasm Metastasis | 2 | 2020 | 610 | 0.170 |
Why?
| Adherens Junctions | 1 | 2020 | 25 | 0.170 |
Why?
| Neoplastic Cells, Circulating | 1 | 2020 | 70 | 0.170 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 383 | 0.160 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 94 | 0.160 |
Why?
| Hormone Replacement Therapy | 1 | 2020 | 92 | 0.160 |
Why?
| Immunoprecipitation | 1 | 2020 | 157 | 0.160 |
Why?
| Neoplasm Invasiveness | 3 | 2020 | 483 | 0.160 |
Why?
| Protein Isoforms | 3 | 2019 | 389 | 0.160 |
Why?
| Cluster Analysis | 4 | 2019 | 479 | 0.160 |
Why?
| Up-Regulation | 2 | 2020 | 839 | 0.160 |
Why?
| Protein Interaction Mapping | 1 | 2020 | 108 | 0.160 |
Why?
| Forkhead Box Protein O1 | 1 | 2019 | 21 | 0.160 |
Why?
| Disease Susceptibility | 1 | 2021 | 333 | 0.150 |
Why?
| Tretinoin | 2 | 2017 | 130 | 0.150 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2020 | 201 | 0.150 |
Why?
| DNA Helicases | 1 | 2000 | 149 | 0.150 |
Why?
| Mass Spectrometry | 2 | 2020 | 713 | 0.150 |
Why?
| Cadherins | 1 | 2020 | 188 | 0.150 |
Why?
| Wnt Signaling Pathway | 1 | 2020 | 170 | 0.150 |
Why?
| Risk | 1 | 2021 | 854 | 0.150 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 52 | 0.150 |
Why?
| Cell Culture Techniques | 1 | 2020 | 336 | 0.140 |
Why?
| Lipids | 1 | 2021 | 625 | 0.140 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1994 | 20 | 0.130 |
Why?
| Glucose Transporter Type 1 | 1 | 2016 | 49 | 0.130 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 428 | 0.130 |
Why?
| Phenylthiohydantoin | 1 | 2016 | 44 | 0.130 |
Why?
| Single-Cell Analysis | 1 | 2019 | 275 | 0.130 |
Why?
| ErbB Receptors | 2 | 2020 | 605 | 0.130 |
Why?
| Cell Membrane | 1 | 2020 | 733 | 0.130 |
Why?
| Disease Models, Animal | 4 | 2016 | 4057 | 0.130 |
Why?
| Tissue Array Analysis | 1 | 2015 | 57 | 0.120 |
Why?
| Ribosomal Proteins | 1 | 2015 | 77 | 0.120 |
Why?
| CD146 Antigen | 3 | 2021 | 41 | 0.120 |
Why?
| Transcriptional Activation | 3 | 2006 | 367 | 0.120 |
Why?
| Mutation | 4 | 2022 | 3710 | 0.120 |
Why?
| Azepines | 1 | 2015 | 88 | 0.110 |
Why?
| Binding Sites | 6 | 2016 | 1250 | 0.110 |
Why?
| Gene Knockdown Techniques | 1 | 2015 | 316 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2012 | 2835 | 0.110 |
Why?
| Neoadjuvant Therapy | 2 | 2021 | 381 | 0.110 |
Why?
| Phenotype | 4 | 2011 | 3074 | 0.110 |
Why?
| Liver Neoplasms | 1 | 2019 | 640 | 0.110 |
Why?
| Glycoproteins | 1 | 2015 | 338 | 0.110 |
Why?
| Endometrial Neoplasms | 1 | 2015 | 164 | 0.110 |
Why?
| RNA, Messenger | 2 | 2019 | 2703 | 0.100 |
Why?
| Peptide Fragments | 3 | 2003 | 692 | 0.100 |
Why?
| Immunohistochemistry | 2 | 2015 | 1691 | 0.100 |
Why?
| Ligands | 3 | 2023 | 621 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 756 | 0.100 |
Why?
| Muscle, Skeletal | 3 | 2001 | 1613 | 0.100 |
Why?
| Chromatin | 1 | 2016 | 478 | 0.100 |
Why?
| CD24 Antigen | 1 | 2012 | 20 | 0.100 |
Why?
| Gene Regulatory Networks | 2 | 2012 | 280 | 0.100 |
Why?
| Mifepristone | 3 | 2020 | 64 | 0.100 |
Why?
| Breast Neoplasms, Male | 1 | 2012 | 29 | 0.100 |
Why?
| Retinoids | 1 | 2012 | 33 | 0.100 |
Why?
| Cell Survival | 1 | 2015 | 1075 | 0.100 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2012 | 67 | 0.090 |
Why?
| Cell Differentiation | 2 | 2012 | 1887 | 0.090 |
Why?
| Small Molecule Libraries | 1 | 2012 | 86 | 0.090 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 169 | 0.090 |
Why?
| Pyrimidines | 1 | 2015 | 459 | 0.090 |
Why?
| Drug Discovery | 1 | 2012 | 131 | 0.090 |
Why?
| Tumor Burden | 1 | 2012 | 286 | 0.090 |
Why?
| Cell Movement | 1 | 2015 | 944 | 0.090 |
Why?
| Receptors, Notch | 1 | 2011 | 84 | 0.090 |
Why?
| HeLa Cells | 4 | 2006 | 611 | 0.090 |
Why?
| Cell Size | 1 | 2010 | 87 | 0.090 |
Why?
| Peptides | 1 | 2015 | 923 | 0.080 |
Why?
| HEK293 Cells | 1 | 2012 | 696 | 0.080 |
Why?
| Peritoneal Neoplasms | 1 | 2010 | 87 | 0.080 |
Why?
| Ovariectomy | 1 | 2010 | 135 | 0.080 |
Why?
| Transforming Growth Factor beta | 1 | 2012 | 455 | 0.080 |
Why?
| Cell Growth Processes | 2 | 2006 | 52 | 0.080 |
Why?
| Adenocarcinoma | 1 | 2015 | 898 | 0.080 |
Why?
| Flow Cytometry | 1 | 2012 | 1155 | 0.080 |
Why?
| Embryonal Carcinoma Stem Cells | 1 | 2008 | 2 | 0.080 |
Why?
| Muscle Fibers, Skeletal | 2 | 2001 | 187 | 0.070 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 170 | 0.070 |
Why?
| Kaplan-Meier Estimate | 2 | 2020 | 851 | 0.070 |
Why?
| Phosphorylation | 3 | 2008 | 1710 | 0.060 |
Why?
| Lung Neoplasms | 1 | 2019 | 2342 | 0.060 |
Why?
| Histone Acetyltransferases | 1 | 2006 | 61 | 0.060 |
Why?
| Amino Acid Sequence | 3 | 2012 | 2056 | 0.060 |
Why?
| Obesity | 1 | 2018 | 2879 | 0.060 |
Why?
| Keratins | 1 | 2005 | 175 | 0.060 |
Why?
| Organ Specificity | 2 | 2010 | 295 | 0.060 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 38 | 0.060 |
Why?
| Models, Biological | 2 | 2008 | 1722 | 0.060 |
Why?
| Gonanes | 2 | 1994 | 27 | 0.050 |
Why?
| Lymph Nodes | 1 | 2006 | 470 | 0.050 |
Why?
| Mice, Transgenic | 2 | 2020 | 2117 | 0.050 |
Why?
| Base Sequence | 3 | 2001 | 2146 | 0.050 |
Why?
| Genes, Reporter | 2 | 2012 | 265 | 0.050 |
Why?
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2022 | 8 | 0.050 |
Why?
| Gene Expression Regulation | 2 | 2022 | 2537 | 0.050 |
Why?
| Mice, Knockout | 2 | 2020 | 2871 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2005 | 422 | 0.050 |
Why?
| Aromatase Inhibitors | 1 | 2021 | 51 | 0.050 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 217 | 0.050 |
Why?
| Nuclear Receptor Coactivator 3 | 1 | 2021 | 6 | 0.050 |
Why?
| Neoplasms | 1 | 2015 | 2449 | 0.050 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2021 | 44 | 0.040 |
Why?
| Nucleosomes | 1 | 2022 | 137 | 0.040 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 39 | 0.040 |
Why?
| Cell Adhesion Molecules | 1 | 2021 | 173 | 0.040 |
Why?
| Ku Autoantigen | 1 | 2000 | 13 | 0.040 |
Why?
| DNA-Activated Protein Kinase | 1 | 2000 | 15 | 0.040 |
Why?
| Glutathione Transferase | 1 | 2000 | 102 | 0.040 |
Why?
| Cell Nucleus | 2 | 2016 | 586 | 0.040 |
Why?
| Methionine | 1 | 2000 | 156 | 0.040 |
Why?
| Carrier Proteins | 1 | 2023 | 742 | 0.040 |
Why?
| Antigens, Neoplasm | 1 | 2021 | 308 | 0.040 |
Why?
| Cell Death | 1 | 2020 | 354 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2020 | 645 | 0.040 |
Why?
| Gene Library | 1 | 2019 | 115 | 0.040 |
Why?
| B7-H1 Antigen | 1 | 2020 | 195 | 0.040 |
Why?
| Datasets as Topic | 1 | 2019 | 109 | 0.040 |
Why?
| DNA, Complementary | 1 | 2019 | 271 | 0.040 |
Why?
| Prognosis | 2 | 2020 | 3773 | 0.040 |
Why?
| Loss of Function Mutation | 1 | 2018 | 39 | 0.040 |
Why?
| Immunologic Memory | 1 | 2020 | 349 | 0.040 |
Why?
| Diaphragm | 1 | 1998 | 42 | 0.040 |
Why?
| Breast | 1 | 2019 | 153 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 2 | 2012 | 372 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2020 | 1247 | 0.040 |
Why?
| Protein Biosynthesis | 1 | 2000 | 405 | 0.040 |
Why?
| Adult | 2 | 2017 | 35495 | 0.040 |
Why?
| Myosins | 1 | 1998 | 133 | 0.040 |
Why?
| Mutagenesis, Site-Directed | 2 | 2001 | 361 | 0.040 |
Why?
| Heterozygote | 1 | 1998 | 272 | 0.030 |
Why?
| Dendritic Cells | 1 | 2020 | 479 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2000 | 648 | 0.030 |
Why?
| Protein Structure, Tertiary | 2 | 2012 | 841 | 0.030 |
Why?
| Autoantigens | 1 | 2000 | 419 | 0.030 |
Why?
| Adaptation, Physiological | 1 | 2001 | 513 | 0.030 |
Why?
| Cyclohexanes | 1 | 2016 | 22 | 0.030 |
Why?
| Transfection | 2 | 2003 | 915 | 0.030 |
Why?
| Luminescent Measurements | 1 | 2016 | 75 | 0.030 |
Why?
| Transduction, Genetic | 1 | 2016 | 128 | 0.030 |
Why?
| Anilides | 1 | 2016 | 72 | 0.030 |
Why?
| AC133 Antigen | 1 | 2015 | 19 | 0.030 |
Why?
| Recombinant Proteins | 2 | 2003 | 1304 | 0.030 |
Why?
| Benzamides | 1 | 2016 | 207 | 0.030 |
Why?
| Nitriles | 1 | 2016 | 172 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 485 | 0.030 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 64 | 0.030 |
Why?
| Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| Cell Count | 1 | 2015 | 311 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1998 | 1036 | 0.030 |
Why?
| Aurora Kinase A | 1 | 2015 | 54 | 0.030 |
Why?
| Hormone Antagonists | 1 | 1995 | 32 | 0.030 |
Why?
| TATA Box | 1 | 1994 | 24 | 0.030 |
Why?
| Fibroblasts | 1 | 2020 | 948 | 0.030 |
Why?
| Mammary Tumor Virus, Mouse | 1 | 1994 | 44 | 0.030 |
Why?
| Weight Gain | 1 | 2018 | 509 | 0.030 |
Why?
| Adipose Tissue | 1 | 2018 | 590 | 0.030 |
Why?
| Software | 1 | 2019 | 606 | 0.030 |
Why?
| Drug Synergism | 1 | 1994 | 370 | 0.030 |
Why?
| Amino Acid Motifs | 2 | 2006 | 213 | 0.030 |
Why?
| Promegestone | 1 | 1993 | 33 | 0.030 |
Why?
| beta-Galactosidase | 1 | 1993 | 77 | 0.030 |
Why?
| Raccoon Dogs | 1 | 2012 | 1 | 0.030 |
Why?
| Foxes | 1 | 2012 | 3 | 0.030 |
Why?
| Wolves | 1 | 2012 | 3 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 140 | 0.030 |
Why?
| Cell Line | 2 | 2001 | 2779 | 0.030 |
Why?
| Acitretin | 1 | 2012 | 3 | 0.030 |
Why?
| Miconazole | 1 | 2012 | 5 | 0.030 |
Why?
| DNA | 2 | 2001 | 1396 | 0.020 |
Why?
| CHO Cells | 1 | 2012 | 154 | 0.020 |
Why?
| Isotretinoin | 1 | 2012 | 23 | 0.020 |
Why?
| Cricetinae | 1 | 2012 | 278 | 0.020 |
Why?
| Luciferases | 1 | 2012 | 147 | 0.020 |
Why?
| Phosphates | 1 | 1993 | 179 | 0.020 |
Why?
| 3' Untranslated Regions | 1 | 2012 | 137 | 0.020 |
Why?
| Claudins | 1 | 2011 | 24 | 0.020 |
Why?
| Dogs | 1 | 2012 | 382 | 0.020 |
Why?
| Glucose | 1 | 2016 | 1001 | 0.020 |
Why?
| Species Specificity | 1 | 2012 | 574 | 0.020 |
Why?
| Male | 3 | 2016 | 63512 | 0.020 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2011 | 79 | 0.020 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2010 | 27 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2012 | 385 | 0.020 |
Why?
| Diet | 1 | 2018 | 1212 | 0.020 |
Why?
| Liver | 1 | 2019 | 1839 | 0.020 |
Why?
| Cohort Studies | 1 | 2020 | 5409 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 2010 | 214 | 0.020 |
Why?
| Protein Processing, Post-Translational | 1 | 2012 | 454 | 0.020 |
Why?
| Protein Kinase Inhibitors | 1 | 2015 | 890 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 947 | 0.020 |
Why?
| Progesterone Congeners | 1 | 2008 | 17 | 0.020 |
Why?
| Microdissection | 1 | 2007 | 15 | 0.020 |
Why?
| Blotting, Western | 1 | 2010 | 1204 | 0.020 |
Why?
| Lasers | 1 | 2007 | 132 | 0.020 |
Why?
| Nuclear Receptor Coactivator 1 | 1 | 2006 | 11 | 0.020 |
Why?
| Mutant Proteins | 1 | 2006 | 99 | 0.020 |
Why?
| Lung | 1 | 2019 | 3927 | 0.020 |
Why?
| Protein Kinases | 1 | 2008 | 318 | 0.020 |
Why?
| Protein Structure, Secondary | 1 | 2006 | 340 | 0.020 |
Why?
| COS Cells | 1 | 2003 | 186 | 0.010 |
Why?
| Analysis of Variance | 1 | 2005 | 1288 | 0.010 |
Why?
| Sequence Alignment | 1 | 2003 | 332 | 0.010 |
Why?
| Mutagenesis | 1 | 2003 | 181 | 0.010 |
Why?
| Uterus | 1 | 2003 | 207 | 0.010 |
Why?
| Sequence Deletion | 1 | 2001 | 179 | 0.010 |
Why?
| Hypertrophy | 1 | 2001 | 121 | 0.010 |
Why?
| Enhancer Elements, Genetic | 1 | 2001 | 176 | 0.010 |
Why?
| Protein Binding | 1 | 2006 | 2120 | 0.010 |
Why?
| Organ Size | 1 | 2001 | 446 | 0.010 |
Why?
| Reference Values | 1 | 2001 | 793 | 0.010 |
Why?
| Body Weight | 1 | 2001 | 939 | 0.010 |
Why?
| Aged | 1 | 2015 | 22032 | 0.010 |
Why?
| Motor Activity | 1 | 2001 | 675 | 0.010 |
Why?
| Feeding Behavior | 1 | 2001 | 622 | 0.010 |
Why?
| Membrane Proteins | 1 | 2001 | 1117 | 0.010 |
Why?
| Middle Aged | 1 | 2015 | 31090 | 0.010 |
Why?
|
|
Sartorius's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|